Women's Health
10 Women’s Health Biotechs to Watch: Beyond the Biology, Toward Equity
Pharma's Almanac
PAO-08-25-NI-08Aug 11, 2025
Autoimmune Diseases
Pain, Misdiagnosis, and Autoimmune Disease: Untangling Complexity and Bias
David Alvaro, Ph.D.; Chia Chia Sun
Pharma's Almanac
PAO-08-25-CL-03Aug 06, 2025
Pediatric Oncology
The Strategic Case for Investing in Pediatric Oncology, Beyond Altruism
Emilee Kudla
Pharma's Almanac
PAO-08-25-NI-04Aug 05, 2025
Pediatric Oncology
The "Therapeutic Winter" and Why Urgent Innovation in Pediatric Oncology Is Being Left Behind
Emilee Kudla
Pharma's Almanac
PAO-08-25-NI-03Aug 05, 2025
Exosomes
Five Exosome Biotechs to Watch: July 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-01Jul 01, 2025
Nanoscale
Addressing Drug Delivery Challenges at the Nanoscale
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-25-NI-07Jun 16, 2025
Rare Disease
Rare Disease Biotech Announces ‘Hugely Significant’ Milestone with Selection of Candidate Drug
SynaptixBio
PR-06-25-NI-02Jun 10, 2025
Fundraising
Sano Women’s Health Raises Funds to Advance Phase 2 Clinical Trials for Novel RVVC Treatment
Sano Women's Health
PR-06-25-NI-01Jun 06, 2025
Protein Design
Reprogramming the Rules: How AI Is Transforming De Novo Protein Design in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-08Apr 15, 2025
First-in-Class Drugs
Breaking New Ground: 30 Years of First-in-Class Drug Innovation
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-27Apr 09, 2025
Microbiome
Innovating to Target the Microbiome for Human Health
Servatus
PAO-11-24-RTM-15Apr 08, 2025
Psychedelics
Unlocking the Potential of Psychedelics for Postpartum Depression
Greg Mayes, J.D.
Reunion Neuroscience
PAO-03-25-CL-05Mar 31, 2025
Drug Approvals
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Pharma's Almanac
PAO-03-25-RT-01Mar 26, 2025
Advocacy
From Patients to Partners: The Rising Power of Advocacy in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-19Mar 13, 2025
Biomarkers
The Biomarker Revolution in Medicine and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-16Mar 10, 2025
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12Mar 02, 2025
Accelerated Approval
30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-07Mar 02, 2025
Structural Biology
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-13Mar 02, 2025
Real-World Evidence
Overcoming Challenges and Unlocking the Potential of Real-World Evidence
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-09Mar 02, 2025
Cannabinoids
Unlocking New Frontiers with Cannabinoid and Psychedelic Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-04Mar 02, 2025